T-DM1 impresses at ASCO

被引：0
|
作者：
Malini Guha
机构：
来源：
Nature Biotechnology | 2012年 / 30卷 / 8期
关键词：
D O I：
10.1038/nbt0812-728
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：728 / 728
相关论文
共 50 条
  • [31] Breast cancer case with multiple brain metastases responding to T-DM1
    Takabatake, Daisuke
    Ohisi, Kazuyuki
    ANNALS OF ONCOLOGY, 2015, 26 : 127 - 127
  • [32] T-DM1 in breast cancer therapeutics: The first drug of its generation
    Karamouzis M.V.
    memo - Magazine of European Medical Oncology, 2013, 6 (4) : 267 - 270
  • [33] T-DM1 for HER2-positive metastatic breast cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (03): : E94 - E94
  • [34] Neutralization of BCL2/XL enhances the cytotoxicity of T-DM1 in vivo
    Zoeller, J. J.
    Dillon, D. A.
    Bronson, R. T.
    Sampath, D.
    Leverson, J.
    Brugge, J. S.
    CANCER RESEARCH, 2017, 77
  • [35] Activity of trastuzumab emtansine (T-DM1) in 3D cell culture
    Boyer, Jean Zheng
    Phillips, Gail D. Lewis
    Nitta, Hiro
    Garsha, Karl
    Admire, Brittany
    Kraft, Robert
    Dennis, Eslie
    Vela, Elizabeth
    Towne, Penny
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 65 - 75
  • [36] Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment
    Arecco, Luca
    Blondeaux, Eva
    Damassi, Alessandra
    Fregatti, Piero
    Lambertini, Matteo
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (02) : 512 - 516
  • [37] mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
    Casadevall, David
    Hernandez-Prat, Anna
    Garcia-Alonso, Sara
    Arpi-Llucia, Oriol
    Menendez, Silvia
    Qin, Mengjuan
    Guardia, Cristina
    Morancho, Beatriz
    Sanchez-Martin, Francisco Javier
    Zazo, Sandra
    Gavilan, Elena
    Sabbaghi, Mohammad A.
    Eroles, Pilar
    Cejalvo, Juan Miguel
    Lluch, Ana
    Rojo, Federico
    Pandiella, Atanasio
    Rovia, Ana
    Anabell, Joan
    MOLECULAR CANCER RESEARCH, 2022, 20 (07) : 1108 - 1121
  • [38] deBouganin conjugated to trastuzumab overcomes multiple mechanisms of T-DM1 drug resistance
    Dillon, Rachelle L.
    Chooniedass, Shilpa
    Premsukh, Arjune
    Adams, Gregory P.
    Entwistle, Joycelyn
    MacDonald, Glen C.
    Cizeau, Jeannick
    CANCER RESEARCH, 2016, 76
  • [39] Locoregional hypofractionated radiotherapy and T-DM1 in breast cancer: a single center experience
    Apicella, Giuseppina
    Scaringi, Claudia
    Ponti, Elisabetta
    Andrulli, Angela Damiana
    Adorisio, Rosamaria
    Costarelli, Leopoldo
    Minelli, Mauro
    Fortunato, Lucio
    Musio, Daniela
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S652 - S655
  • [40] Breast cancer brain metastases responding to primary systemic therapy with T-DM1
    Rupert Bartsch
    Anna S. Berghoff
    Matthias Preusser
    Journal of Neuro-Oncology, 2014, 116 : 205 - 206
12345